Copyright
©The Author(s) 2017.
World J Clin Oncol. Apr 10, 2017; 8(2): 151-157
Published online Apr 10, 2017. doi: 10.5306/wjco.v8.i2.151
Published online Apr 10, 2017. doi: 10.5306/wjco.v8.i2.151
Type of cancer | Total = 124 (n, %) | BETHESDA (n, %) | |||||
I | II | III | IV (n = 25) | V | VI | ||
PTC | |||||||
Classic variant | 57 | 1 | 5 | 1 | 3 | 8 | 39 |
Follicular variant | 34 | 1 | 8 | 2 | 11 | 6 | 6 |
Conventional | 19 | 0 | 2 | 2 | 3 | 3 | 9 |
Tall-cell variant | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
Total PTC | 111 (89.6) | 2 | 15 | 5 | 17 (68) | 17 | 55 |
FTC | |||||||
MIFTC | 10 | 0 | 1 | 1 | 7 | 1 | 0 |
WIFTC | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
Total FTC | 11 (8.9) | 0 | 1 | 1 | 8 (32) | 1 | 0 |
MTC | 1 (0.8) | 0 | 0 | 0 | 0 | 0 | 1 |
ATC | 1 (0.8) | 0 | 0 | 0 | 0 | 0 | 1 |
- Citation: Al Dawish MA, Robert AA, Muna A, Eyad A, Al Ghamdi A, Al Hajeri K, Thabet MA, Braham R. Bethesda System for Reporting Thyroid Cytopathology: A three-year study at a tertiary care referral center in Saudi Arabia. World J Clin Oncol 2017; 8(2): 151-157
- URL: https://www.wjgnet.com/2218-4333/full/v8/i2/151.htm
- DOI: https://dx.doi.org/10.5306/wjco.v8.i2.151